granisetron normon 3 mg/3 ml solucion inyectable efg
laboratorios normon s.a. - granisetron hidrocloruro - soluciÓn inyectable - 3 mg - granisetron hidrocloruro 1 mg - granisetrón
granisetron accord 3mg/3ml solucion inyectable efg
accord healthcare s.l.u. - granisetron - soluciÓn inyectable - 3 mg - granisetron 1 mg - granisetrón
granisetron aurovitas spain 1 mg comprimidos recubiertos con película efg
aurovitas spain, s.a.u. - granisetron hidrocloruro - comprimido recubierto con pelÍcula - 1 mg - granisetron hidrocloruro 1 mg - granisetrón
granisetron altan 1 mg comprimidos recubiertos con pelicula efg
altan pharmaceuticals sa - granisetron hidrocloruro - comprimido recubierto con pelÍcula - 1 mg - granisetron hidrocloruro 1 mg - granisetrón
granisetron altan 3 mg/3 ml concentrado para solucion para perfusion efg
altan pharmaceuticals sa - granisetron hidrocloruro - concentrado para soluciÓn para perfusiÓn - 3 mg - granisetron hidrocloruro 1 mg - granisetrón
granisetron altan 3 mg/50 ml solucion para perfusion
altan pharmaceuticals sa - granisetron hidrocloruro - soluciÓn para perfusiÓn - 3 mg - granisetron hidrocloruro 0.06 mg - granisetrón
granisetron kabi 1 mg/ml concentrado para solucion inyectable efg
fresenius kabi espaÑa, s.a.u. - granisetron hidrocloruro - concentrado para soluciÓn inyectable - 3 mg - granisetron hidrocloruro 1 mg - granisetrón
granisetron normon 1 mg/1 ml solucion inyectable efg
laboratorios normon s.a. - granisetron hidrocloruro - soluciÓn inyectable - 1 mg - granisetron hidrocloruro 1 mg - granisetrón
granisetron hydrochloride injection
wockhardt usa llc. - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron 0.1 mg in 1 ml - granisetron hydrochloride injection is a serotonin-3 (5-ht3 ) receptor antagonist indicated for: - the prevention of nausea and/or vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. granisetron hydrochloride injection is contraindicated in patients with known hypersensitivity (eg. anaphylaxis, shortness of breath, hypotension, urticaria) to the drug or to any of its components. pregnancy category b reproduction studies have been performed in pregnant rats at intravenous doses up to 9 mg/kg/day (54 mg/m2 /day, 146 times the recommended human dose based on body surface area) and pregnant rabbits at intravenous doses up to 3 mg/kg/day (35.4 mg/m2 /day, 96 times the recommended human dose based on body surface area) and have revealed no evidence of impaired fertility or harm to the fetus due to granisetron. there are, however, no adequate and well-controlled studies in pregnant women. because animal reproduction studies are not always predi
granisetron hydrochloride injection
wockhardt usa llc. - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron 1 mg in 1 ml - granisetron hydrochloride injection is a serotonin-3 (5-ht3 ) receptor antagonist indicated for: - the prevention of nausea and/or vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. granisetron hydrochloride injection is contraindicated in patients with known hypersensitivity (eg. anaphylaxis, shortness of breath, hypotension, urticaria) to the drug or to any of its components. pregnancy category b reproduction studies have been performed in pregnant rats at intravenous doses up to 9 mg/kg/day (54 mg/m2 /day, 146 times the recommended human dose based on body surface area) and pregnant rabbits at intravenous doses up to 3 mg/kg/day (35.4 mg/m2 /day, 96 times the recommended human dose based on body surface area) and have revealed no evidence of impaired fertility or harm to the fetus due to granisetron. there are, however, no adequate and well-controlled studies in pregnant women. because animal reproduction studies are not always predi